DNA repair: From genome maintenance to biomarker and therapeutic target

Shadia Jalal, Jennifer N. Earley, John J. Turchi

Research output: Contribution to journalReview article

64 Citations (Scopus)

Abstract

A critical link exists between an individual's ability to repair cellular DNA damage and cancer development, progression, and response to therapy. Knowledge gained about the proteins involved and types of damage repaired by the individual DNA repair pathways has led to the development of a variety of assays aimed at determining an individual's DNA repair capacity. These assays and their use in the analysis of clinical samples have yielded useful though somewhat conflicting data. In this review article, we discuss the majorDNArepair pathways, the proteins and genes required for each, assays used to analyze activity, and the relevant clinical studies to date. With the recent results from clinical trials targeting specific DNA repair proteins for the treatment of cancer, accurate, reproducible, and relevant analysis of DNA repair takes on an even greater significance. We highlight the strengths and limitations of these DNA repair studies and assays, with respect to the clinical assessment of DNA repair capacity to determine cancer development and response to therapy.

Original languageEnglish (US)
Pages (from-to)6973-6984
Number of pages12
JournalClinical Cancer Research
Volume17
Issue number22
DOIs
StatePublished - Nov 15 2011

Fingerprint

DNA Repair
Biomarkers
Maintenance
Genome
Therapeutics
Neoplasms
Proteins
DNA Damage
Clinical Trials

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

DNA repair : From genome maintenance to biomarker and therapeutic target. / Jalal, Shadia; Earley, Jennifer N.; Turchi, John J.

In: Clinical Cancer Research, Vol. 17, No. 22, 15.11.2011, p. 6973-6984.

Research output: Contribution to journalReview article

@article{a81fbe5770024084be744a8667e82815,
title = "DNA repair: From genome maintenance to biomarker and therapeutic target",
abstract = "A critical link exists between an individual's ability to repair cellular DNA damage and cancer development, progression, and response to therapy. Knowledge gained about the proteins involved and types of damage repaired by the individual DNA repair pathways has led to the development of a variety of assays aimed at determining an individual's DNA repair capacity. These assays and their use in the analysis of clinical samples have yielded useful though somewhat conflicting data. In this review article, we discuss the majorDNArepair pathways, the proteins and genes required for each, assays used to analyze activity, and the relevant clinical studies to date. With the recent results from clinical trials targeting specific DNA repair proteins for the treatment of cancer, accurate, reproducible, and relevant analysis of DNA repair takes on an even greater significance. We highlight the strengths and limitations of these DNA repair studies and assays, with respect to the clinical assessment of DNA repair capacity to determine cancer development and response to therapy.",
author = "Shadia Jalal and Earley, {Jennifer N.} and Turchi, {John J.}",
year = "2011",
month = "11",
day = "15",
doi = "10.1158/1078-0432.CCR-11-0761",
language = "English (US)",
volume = "17",
pages = "6973--6984",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - DNA repair

T2 - From genome maintenance to biomarker and therapeutic target

AU - Jalal, Shadia

AU - Earley, Jennifer N.

AU - Turchi, John J.

PY - 2011/11/15

Y1 - 2011/11/15

N2 - A critical link exists between an individual's ability to repair cellular DNA damage and cancer development, progression, and response to therapy. Knowledge gained about the proteins involved and types of damage repaired by the individual DNA repair pathways has led to the development of a variety of assays aimed at determining an individual's DNA repair capacity. These assays and their use in the analysis of clinical samples have yielded useful though somewhat conflicting data. In this review article, we discuss the majorDNArepair pathways, the proteins and genes required for each, assays used to analyze activity, and the relevant clinical studies to date. With the recent results from clinical trials targeting specific DNA repair proteins for the treatment of cancer, accurate, reproducible, and relevant analysis of DNA repair takes on an even greater significance. We highlight the strengths and limitations of these DNA repair studies and assays, with respect to the clinical assessment of DNA repair capacity to determine cancer development and response to therapy.

AB - A critical link exists between an individual's ability to repair cellular DNA damage and cancer development, progression, and response to therapy. Knowledge gained about the proteins involved and types of damage repaired by the individual DNA repair pathways has led to the development of a variety of assays aimed at determining an individual's DNA repair capacity. These assays and their use in the analysis of clinical samples have yielded useful though somewhat conflicting data. In this review article, we discuss the majorDNArepair pathways, the proteins and genes required for each, assays used to analyze activity, and the relevant clinical studies to date. With the recent results from clinical trials targeting specific DNA repair proteins for the treatment of cancer, accurate, reproducible, and relevant analysis of DNA repair takes on an even greater significance. We highlight the strengths and limitations of these DNA repair studies and assays, with respect to the clinical assessment of DNA repair capacity to determine cancer development and response to therapy.

UR - http://www.scopus.com/inward/record.url?scp=81255138410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255138410&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-11-0761

DO - 10.1158/1078-0432.CCR-11-0761

M3 - Review article

C2 - 21908578

AN - SCOPUS:81255138410

VL - 17

SP - 6973

EP - 6984

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 22

ER -